Zobrazeno 1 - 10
of 133
pro vyhledávání: '"Jacques Belaiche"'
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 3 (2010)
Crohn’s disease (CD) and ulcerative colitis (UC) are chronic inflammatory bowel diseases which can be difficult to control with conventional therapies. A greater understanding of their pathophysiology has led to new therapies that target specific m
Externí odkaz:
https://doaj.org/article/d74c835434dd450ca91798ea7ff85b3d
Autor:
Alexandra-Chloé Villani, Mathieu Lemire, Edouard Louis, Mark S Silverberg, Catherine Collette, Geneviève Fortin, Elaine R Nimmo, Yannick Renaud, Sébastien Brunet, Cécile Libioulle, Jacques Belaiche, Alain Bitton, Daniel Gaudet, Albert Cohen, Diane Langelier, John D Rioux, Ian D R Arnott, Gary E Wild, Paul Rutgeerts, Jack Satsangi, Séverine Vermeire, Thomas J Hudson, Denis Franchimont
Publikováno v:
PLoS ONE, Vol 4, Iss 9, p e7154 (2009)
The familial Mediterranean fever (FMF) gene (MEFV) encodes pyrin, a major regulator of the inflammasome platform controlling caspase-1 activation and IL-1beta processing. Pyrin has been shown to interact with the gene product of NLRP3, NALP3/cryopyri
Externí odkaz:
https://doaj.org/article/dd0119c4b4a24805b544a4aa771cbfb2
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 2 (2009)
Crohn's disease is a heterogeneous disease with approximately 30-40% of patients having a simple benign history and the rest having a chronic progressive disease leading to complications, surgeries and potentially socio-professional marginalisation.
Externí odkaz:
https://doaj.org/article/5761e03fc3074056ba75a6a6e81c0b79
Autor:
Cécile Libioulle, Edouard Louis, Sarah Hansoul, Cynthia Sandor, Frédéric Farnir, Denis Franchimont, Séverine Vermeire, Olivier Dewit, Martine de Vos, Anna Dixon, Bruno Demarche, Ivo Gut, Simon Heath, Mario Foglio, Liming Liang, Debby Laukens, Myriam Mni, Diana Zelenika, André Van Gossum, Paul Rutgeerts, Jacques Belaiche, Mark Lathrop, Michel Georges
Publikováno v:
PLoS Genetics, Vol 3, Iss 4, p e58 (2007)
To identify novel susceptibility loci for Crohn disease (CD), we undertook a genome-wide association study with more than 300,000 SNPs characterized in 547 patients and 928 controls. We found three chromosome regions that provided evidence of disease
Externí odkaz:
https://doaj.org/article/14badae124fb4fb19fb28982d2905bee
Autor:
Idar Lygren, Jonas Koch, Severine Vermeire, Geert DʼHaens, Filip Baert, Jørgen Jahnsen, Inger Camilla Solberg, Edouard Louis, Fernand Fontaine, Tore Grimstad, Roald Torp, Lars Normann Karlsen, Olivier Dewit, D Staessen, Martine De Vos, Jean-Claude R J Coche, Fazia Mana, Guy Lambrecht, Vinciane Muls, Maja Noman, Thomas de Lange, Bert Vander Cruyssen, Philippe M R Potvin, Gert A. Van Assche, Pieter Hindryckx, André Van Gossum, Magne Henriksen, Cool M, Jacques Belaiche, Jo G P Vandervoort, Jean-Marc Maisin, Denis Franchimont, Eirik Kittang, Bart Neuville, Arnaud Collard, Philippe Van Hootegem, Tom G. Moreels
Publikováno v:
Inflammatory bowel diseases
Inflammatory bowel diseases, 19(10), 2111-2117. John Wiley and Sons Inc.
Inflammatory bowel diseases, 19(10), 2111-2117. John Wiley and Sons Inc.
Background:This study examined whether fecal calprotectin can be used in daily practice as a marker to monitor patients with ulcerative colitis (UC) receiving infliximab maintenance therapy.Methods:This prospective multicenter study enrolled adult pa
Autor:
Jerome I. Rotter, Elaine R. Nimmo, Jeffrey C. Barrett, Jacques Belaiche, Cynthia Sandor, Martine De Vos, Natalie J. Prescott, Mark J. Daly, André Van Gossum, Dan L. Nicolae, Alain Bitton, A. Hillary Steinhart, Christopher G. Mathew, Rhian Gwilliam, L. Philip Schumm, M. Michael Barmada, Panos Deloukas, Olivier Dewit, Severine Vermeire, Debby Laukens, Miguel Regueiro, Edouard Louis, Kent D. Taylor, Cécile Libioulle, Jonathan Marchini, Carl A. Anderson, Emily O. Kistner, Judy H. Cho, John D. Rioux, Simon Heath, Clive M. Onnie, Themistocles Dassopoulos, John C. Mansfield, Myriam Mni, Jack Satsangi, Mark Tremelling, Jean-Pierre Hugot, Hazel E. Drummond, Ramnik J. Xavier, Mark Lathrop, Michel Georges, Steven R. Brant, Lon R. Cardon, Miles Parkes, Jilur Ghori, Tariq Ahmad, Michael T. Murtha, Mark S. Silverberg, Stephan R. Targan, Suzannah Bumpstead, Ivo Gut, Todd Green, Derek P. Jewell, Richard H. Duerr, Denis Franchimont, Paul Rutgeerts, Anne M. Griffiths, Sarah Hansoul, Diana Zelenika, Sheila A. Fisher, Lisa W. Datta
Publikováno v:
Barrett, J C, Hansoul, S, Nicolae, D L, Cho, J H, Duerr, R H, Rioux, J D, Brant, S R, Silverberg, M S, Taylor, K D, Barmada, M M, Bitton, A, Dassopoulos, T, Datta, L W, Green, T, Griffiths, A M, Kistner, E O, Murtha, M T, Regueiro, M D, Rotter, J I, Schumm, L P, Steinhart, A H, Targan, S R, Xavier, R J, Libioulle, C, Sandor, C, Lathrop, M, Belaiche, J, Dewit, O, Gut, I, Heath, S, Laukens, D, Mni, M, Rutgeerts, P, Van Gossum, A, Zelenika, D, Franchimont, D, Hugot, J-P, de Vos, M, Vermeire, S, Louis, E, Cardon, L R, Anderson, C A, Drummond, H, Nimmo, E, Ahmad, T, Prescott, N J, Onnie, C M, Fisher, S A, Marchini, J, Satsangi, J 2008, ' Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease ', Nature Genetics, vol. 40, no. 8, pp. 955-962 . https://doi.org/10.1038/ng.175
Several risk factors for Crohn's disease have been identified in recent genome-wide association studies. To advance gene discovery further, we combined data from three studies on Crohn's disease ( a total of 3,230 cases and 4,829 controls) and carrie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30fa0ca81d62e96134d54a1b8cfb7e2a
https://ora.ox.ac.uk/objects/uuid:ab25b55e-6edf-4037-b9d3-058c8e785d37
https://ora.ox.ac.uk/objects/uuid:ab25b55e-6edf-4037-b9d3-058c8e785d37
Autor:
Satish Keshav, Catherine Reenaers, Jacques Belaiche, Simon Travis, Laurence Seidel, Edouard Louis
Summary Background There is clear benefit from combination therapy with infliximab and immunosuppressive drugs (IS), but few data are available for adalimumab (ADA). Aim To assess the efficacy of ADA monotherapy and ADA+IS for induction and maintenan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fa1cc9edb2bf5f5d13aea51a9631361
https://ora.ox.ac.uk/objects/uuid:172c69a4-3e35-4986-828c-151f8ea59761
https://ora.ox.ac.uk/objects/uuid:172c69a4-3e35-4986-828c-151f8ea59761
Autor:
Pascale Latour, Jacques Belaiche, Catherine Reenaers, C. Vankemseke, Edouard Louis, C. Pirard
Publikováno v:
Scandinavian journal of gastroenterology. 51(6)
Crohn's disease (CD) and ulcerative colitis (UC) are potentially progressive diseases. Few data are available on the prevalence and the factors associated with mild inflammatory bowel diseases (IBD).Our aim was to assess the natural history of mild C
Publikováno v:
Journal of Crohn's and Colitis. 5:196-202
Introduction Mesalazine remains the first line treatment for the induction and the maintenance of remission in mild to moderate ulcerative colitis (UC). Its efficacy as a maintenance treatment after a first flare treated with corticosteroids has not